Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
An eight week comparison of the investigational drug GW590735, placebo, and the marketed drug
fenofibrate intended to increase the levels of "good cholesterol" and decrease levels of "bad
cholesterol" in healthy patients with low levels of good cholesterol and high levels of bad
cholesterol.